CL2012000462A1 - Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's. - Google Patents

Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's.

Info

Publication number
CL2012000462A1
CL2012000462A1 CL2012000462A CL2012000462A CL2012000462A1 CL 2012000462 A1 CL2012000462 A1 CL 2012000462A1 CL 2012000462 A CL2012000462 A CL 2012000462A CL 2012000462 A CL2012000462 A CL 2012000462A CL 2012000462 A1 CL2012000462 A1 CL 2012000462A1
Authority
CL
Chile
Prior art keywords
pharmaceutical composition
alzheimer
useful
treatment
derived compounds
Prior art date
Application number
CL2012000462A
Other languages
Spanish (es)
Inventor
Murali Chebrolu
Konstanze Hurth
Philipp Holzer
Mathias Frederiksen
Sangamesh Badiger
Rainer Martin Lueoend
Rainer Machauer
Henrik Moebitz
Ulf Neumann
Rita Ramos
Heinrich Rueeger
Michael Schaefer
Marina Tintelnot-Blomley
Siem Jacob Veenstra
Markus Voegtle
Hui Liu
Xin Xiong
Lei Li
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2012000462A1 publication Critical patent/CL2012000462A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DAN A CONOCER DERIVADOS DE OXAZINA SELECCIONADOS A PARTIR DEL GRUPO QUE CONSISTE DE: LOS CUALES TIENEN UNA ACTIVIDAD INHIBIDORA DE BACE, EN FORMA LIBRE O EN FORMA DE SAL, Y UNA COMPOSICION FARMACEUTICA QUE LOS CONTIENE.SELECTED OXAZINE DERIVATIVES ARE DISCLOSED FROM THE GROUP THAT CONSISTS OF: WHICH HAVE A BACE INHIBITOR ACTIVITY, IN FREE OR IN THE FORM OF SALT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM.

CL2012000462A 2010-01-12 2012-02-23 Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's. CL2012000462A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43205810P 2010-01-12 2010-01-12
US36370210P 2010-07-13 2010-07-13
EP10060718 2010-07-23
US201161435088P 2011-01-21 2011-01-21

Publications (1)

Publication Number Publication Date
CL2012000462A1 true CL2012000462A1 (en) 2012-09-07

Family

ID=69650475

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000462A CL2012000462A1 (en) 2010-01-12 2012-02-23 Oxazine derived compounds, bace inhibitors; pharmaceutical composition comprising them; Useful in the treatment of Alzheimer's.

Country Status (1)

Country Link
CL (1) CL2012000462A1 (en)

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
CY1123033T1 (en) SPIROCYCLIC CATHEPSIN C INHIBITORS
BR112015020466A8 (en) cdc7 inhibitors, their uses, and pharmaceutical composition
JOP20190142B1 (en) 7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant idh1 and idh2 inhibitors
EA201001847A1 (en) COMPOUNDS AND COMPOSITIONS APPLICABLE FOR THE TREATMENT OF MALARIA
BR112014028042A2 (en) nampt inhibitors
MX373123B (en) DEUTERATED DERIVATIVES OF RUXOLITINIB.
EA201590165A1 (en) CONTAINING ABUSE OF PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED LIBERATION
UY32730A (en) CYP17 INHIBITORS
BR112014017021A2 (en) irak inhibitors and uses thereof
EA201201648A1 (en) SGC STIMULATORS
PE20121617A1 (en) OXAZINE DERIVATIVES AS BACE INHIBITORS
UA111717C2 (en) ORAL INTRODUCTION AND METHYLNALTREXON LIPOPHILIC SALTS
CR20110449A (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN AND PROCESSES TO PRODUCE THE SAME
UY33665A (en) PEPTIDE DERIVATIVE
CY1119426T1 (en) clothes detergent
EA201590296A1 (en) DEUTERATED IBRUTINIB
HN2012000023A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
TR201818825T4 (en) LNCRNAS FOR THE TREATMENT AND DIAGNOSIS OF CARDIAC HYPERTROPHY
BR112013004850A2 (en) treatment of myocardial infarction using tgf-beta antagonists
TR201909923T4 (en) Composition containing the pyrazole derivative for the prevention or treatment of kidney disease.
CY1122313T1 (en) ORBEPITANTE FOR THE TREATMENT OF CHRONIC IGNITION
CL2014001861A1 (en) Compounds derived from benzyl sulfonamide, mogat-2 inhibitors; crystalline compound; pharmaceutical composition; and its use in the treatment of hypertriglyceridemia.
EA201591180A1 (en) COMPOSITIONS OF THE LFA-1 INHIBITOR